ask="34.47"
ask_size="100"
average_daily_volume="71324"
bid="N/A"
bid_size="N/A"
book_value="1.19"
change="+0.03"
change_from_200_day_moving_average="-0.82"
change_from_50_day_moving_average="0.07"
change_from_52_week_high="-3.38"
change_From_52_week_low="0.58"
change_in_percent="+0.98%"
close="3.09"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="-0.83"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="5308000"
high="3.20"
high_52_weeks="6.47"
last_trade_date="2/27/2017"
last_trade_price="3.09"
last_trade_size="180"
last_trade_time="4:00pm"
low="2.95"
low_52_weeks="2.51"
market_capitalization="19.45M"
moving_average_200_day="3.91"
moving_average_50_day="3.02"
name="MABVAX THERAPEUTICS"
notes="N/A"
one_year_target_price="18.00"
open="3.08"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-20.95%"
percent_change_from_50_day_moving_average="+2.49%"
percent_change_from_52_week_high="-52.28%"
percent_change_from_52_week_low="+22.92%"
previous_close="3.06"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.57"
price_per_sales="21.27"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="7.82"
stock_exchange="NCM"
symbol="MBVX"
volume="48422"
weeks_range_52="2.51 - 6.47"
